Scythian Shares Update from Operations in Colombia

- May 16th, 2018

Scythian Biosciences announced a Colombian based company it is in the process of acquiring, ColCanna SAS, obtained a cultivation and importation of non-psychoactive cannabis license.

Scythian Biosciences (TSXV:SCYB) announced a Colombian based company it is in the process of acquiring, ColCanna SAS, obtained a cultivation and importation of non-psychoactive cannabis license.

As quoted in the press release:

Additionally, ColCanna has entered into an exclusive international supply agreement for Colombia (the “Supply Agreement”) with Aphria Inc. (TSX:APH) (“Aphria”), a prominent Canadian low-cost producer of medical cannabis.

Under the terms of the Supply Agreement, Aphria will supply ColCanna with cannabis products for research and development purposes as well as distribution to hospitals, retail pharmacies, and private health providers in Colombia’s public health system.

“Through the expansion of our partnership with Aphria, it is with great pleasure that I announce our entry into the Colombia market as the first supplier of Aphria’s pharma grade medicinal CBD oil in the country,” said CEO Rob Reid. “As we work to finalize the acquisition of ColCanna, we are eager to work hand and hand with Aphria to establish ColCanna as an international supplier of research-backed cannabis products.”

Click here to read the full press release.

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time

Tags

Leave a Reply

Your email address will not be published. Required fields are marked *